The Road to Innovation in 100 Years of German Enterprises: Interpreting the Story Behind The New Brand of Sedulis

In 2020, on its 150th anniversary, the global biopharmaceutical industry partner, Sedulis, announced the launch of a new brand image, Simplifying Progress, to help scientists and engineers streamline processes and accelerate innovation and progress in biomedical fields through innovative products and technologies.
a German company with more than 100 years of history, Sedulis aims to realize its vision of leading the industry in technological innovation with a new concept.
by empowering the global life sciences and biopharmaceutical sectors, Sedulis is gradually living up to its vision of "improving the health of more people through technological breakthroughs."
from the creator of the short-arm balance to the bio-craft enterprise known as the "father of the world's balance" Sedulis was able to maintain success for such a long time, because of its sincere ingenuity.
this spirit can be traced back to its original founder, Mr. Florenz Sartorius.
Florenz Sartorius, born in the nineteenth century, is a mechanic at the University of Augusta in G?ttingen, Germany, specializing in the production of experimental tools and instruments for the university's research laboratory.
his revolutionary invention of short-arm analytical balances, dramatically reducing the time required for accurate scientific measurements.
1870, he founded his own company, Sedolis, in Gottingen, Germany.
time spanned the twentieth century.
1918, Richard Sigmundi, a Hungarian chemist of German descent and later a Nobel laureate, invented membrane filtration.
he co-founded a joint venture with Mr. Wilhelm Sartorius and implemented a large-scale commercial application of the technology.
, the company promoted the continuous improvement of membrane filtration technology and eventually became the predecessor of the Cydris Biotech Division.
the 1990s, the bio-industry experienced large-scale development.
good goodwill and deep technical precipitation have enabled Sedulis to continue to make complementary alliances and acquisitions and to become an international provider of holistic solutions for life sciences and biotechnologies.
installed more than 100,000 units 400,000 units between the two countries alone.
in April, Sedris completed acquisitions of some of Danaher's life sciences businesses, including ForteBio® Molecular Interaction System, Solohill® micros carriers, chromatography resins, columns and systems, and one-time cut-in flow filtration systems.
this point, Sedulis successfully opened up the biopharmaceutical upstream and downstream complete industrial chain, expanded the biopharmaceutical research and development field of the product lineup, become a bio-process enterprises.
philosophy of innovation, which has been complicated into simplicity, believes that simplicity is a kind of wisdom.
simple, is a strong research and development strength and excellence of the spirit of innovation.
the core values and pursuits behind the brand's new brand image, which is based on the brand's manifesto, is to help scientists and engineers streamline processes and accelerate innovation and progress in biomedical fields through innovative products and technologies. For more than
years, Sedulis has been working to increase productivity through the automation and intelligence of bio-processes through pioneering research and innovation, with the aim of helping scientists and engineers around the world simplify and accelerate the development of life sciences and bio-processes with advanced products and technologies to introduce new drugs that are more effective and cost-effective.
Sedris recently announced its stake in the German Center for Artificial Intelligence Research (DFKI) and the establishment of SAIL Laboratories to explore the application of machine learning, image and pattern recognition technologies in the life sciences, including the development of new deep learning algorithms, image recognition of cells and organs, analysis and modeling of biological systems, and simulation and optimization of biomedical production processes.
"We can anticipate the limitless potential of using artificial intelligence processes to develop active pharmaceutical ingredients, which are faster and more cost-effective than the time-consuming and cost-intensive trial-and-error processes that are common today, and can then deliver new treatments to more patients as early as possible."
" - Dr. Joachim Kreuzburg, Chairman and CEO of Theodores Executive Board, has rooted in China and witnessed an extraordinary year in 2020.
outbreak broke out in March this year, and Sedulis earlier invested in support of vaccine development in China.
The first approved clinical vaccine, Ad5-nCoV, led by Concino, was developed using Sedolis's single-use bioreacter system BIOSTAT®STR for upstream vaccine preparation and quality control using microbiological testing equipment and consumables.
this isn't the first time Sedulis has fought alongside the local biopharmaceutical industry.
fact, this year is the 25th year that Seddris is in China.
years, Seddris has been adhering to the concept of "In China, For China", bringing advanced Research and development and process technology from Europe to China to help the development of the local biopharmaceutical industry.
develop a long-term development strategy centered on local customers in China, and implement localized applications that are close to the user through continuous in-depth understanding of the actual needs of Chinese customers.
's faith in China is not a slogan.
In September this year, Sedulis' one-time bioreactive bags and consumables were officially put into operation at its Beijing plant, marking Sedulis as the industry's leading supplier of one-time bioreactive bags and consumables for local production, reflecting Sedulis' confidence and determination to implement China's localization strategy.
the future, Sedulis will set up an application center 3.0 and validation laboratory in China, continue to increase investment in China, to achieve more equipment local production, root soil, energy industry.
"Improving the health of more people through technological breakthroughs" is Sedulis's vision.
hundred years, Sedollis has not forgotten his first heart, and his sincere ingenuity has helped Himdollis achieve sustained success.
future, Sedris will continue to innovate, with the concept of "simplified" innovation to help China's biopharmaceutical industry development.
is willing to work hand in hand with Chinese biopharmaceutical companies to write a new chapter in the development of China's medical and health undertakings.